Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Lira Pump Trial
NCT02351232Phase 3Completed
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- Feb 2015
- Primary completion
- Oct 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of liraglutide in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Copenhagen University Hospital - Hvidovre. Primary endpoint: Change in Hemoglobin A1c at 6 months. Started Feb 2015; status: completed.
02
Drugs
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02351232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02351232.